Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Reiko Arakawa
Observed names:
R. Arakawa,
Reiko Arakawa Masayuki Arakawa,
荒川 玲子,
荒川玲子
Institutions:
National Center for Global Health and Medicine,
Center Hospital of National Center for Global Health and Medicine,
Medical Genomics Center, Japan Institute for Health Security,
Japan Institute for Health Security
Observed institutions:
National Center for Global Health and Medicine,
Tokyo Women's Medical University,
Center Hospital of National Center for Global Health and Medicine,
Medical Genomics Center, Japan Institute for Health Security,
Japan Institute for Health Security
ORCID:
0000-0002-0910-8910
Observed ORCID:
0000-0002-0910-8910
OpenAlex ID:
A5064095854
Works
27
Awards
3
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial
2021
·
Eugenio Mercuri
, Nicolas Deconinck
, et al.
·
The Lancet Neurology
·
269
A new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein
2018
·
Noriko Otsuki
, Reiko Arakawa
, et al.
·
PLoS ONE
·
27
PDF
Relationships between long-term observations of motor milestones and genotype analysis results in childhood-onset Japanese spinal muscular atrophy patients
2017
·
Kaori Kaneko
, Reiko Arakawa
, et al.
·
Brain and Development
·
25
Human first-trimester chorionic villi have a myogenic potential
2012
·
Reiko Arakawa
, Ryoko Aoki
, et al.
·
Cell and Tissue Research
·
14
PDF
Incidence of infantile spinal muscular atrophy on Shikoku Island of Japan
2018
·
Kentaro Okamoto
, Mitsumasa Fukuda
, et al.
·
Brain and Development
·
12
Analysis of spinal muscular atrophy-like patients by targeted resequencing
2019
·
Shinichi Hosokawa
, Yuji Kubo
, et al.
·
Brain and Development
·
9
A novel evaluation method of survival motor neuron protein as a biomarker of spinal muscular atrophy by imaging flow cytometry
2014
·
Masayuki Arakawa
, Reiko Arakawa
, et al.
·
Biochemical and Biophysical Research Communications
·
9
Imaging Flow Cytometry Analysis to Identify Differences of Survival Motor Neuron Protein Expression in Patients With Spinal Muscular Atrophy
2016
·
Reiko Arakawa
, Masayuki Arakawa
, et al.
·
Pediatric Neurology
·
8
Venous thromboembolism is caused by prothrombin p.Arg541Trp mutation in Japanese individuals
2021
·
Jumpei Yamamoto
, Masaya Yamamoto
, et al.
·
Human Genome Variation
·
7
PDF
Seventeen primary malignant neoplasms involving the skin, ovary, esophagus, colon, oral cavity, and ear canal: a case report and review of the literature
2021
·
Ryusuke Sumiya
, Kyoji Ito
, et al.
·
Clinical Journal of Gastroenterology
·
5
Survey of patients with spinal muscular atrophy on the island of Shikoku, Japan
2020
·
Kentaro Okamoto
, Takahiro Motoki
, et al.
·
Brain and Development
·
5
Safety of Risdiplam in Japanese Patients with Spinal Muscular Atrophy: A 12‑Month Interim Analysis of a Postmarketing Surveillance Study
2025
·
Kayoko Saito
, Toshio Saito
, et al.
·
Neurology and Therapy
·
3
PDF
Case Report of Left Ventricular Noncompaction Cardiomyopathy Characterized by Undulating Phenotypes in Adult Patients
2021
·
Wataru Miyake
, Mayu Minemoto
, et al.
·
International Heart Journal
·
3
PDF
Utility and Limitations of Genetic Testing in the Routine Care of Cardiovascular Disease Patients in a General Hospital
2025
·
Daiki Tomidokoro
, Kotaro Mori
, et al.
·
International Heart Journal
·
2
PDF
Evaluation of cardiac function in patients with SMA after treatment with onasemnogene abeparvovec
2025
·
Akihisa Horigome
, Satoshi Takasago
, et al.
·
Pediatrics International
·
2
PDF
Hereditary Hemorrhagic Telangiectasia Presenting with Asymptomatic Liver Lesions and a History of Early-onset Myocardial Infarction and Multiple Intracranial Aneurysms
2022
·
Maki Sakuma
, Takeshi Inagaki
, et al.
·
Internal Medicine
·
1
PDF
Ultra-early treatment initiated at 9 days of age for spinal muscular atrophy: a case report
2026
·
Kotaro Mori
, Masato Isono
, et al.
·
Brain and Development Case Reports
PDF
Characteristics of early-onset, rapidly progressive scoliosis in spinal muscular atrophy type I treated with disease-modifying therapy -a multicenter retrospective study conducted in Japan-
2026
·
Tomokazu Kimizu
, Reiko Arakawa
, et al.
·
Journal of Neuromuscular Diseases
Genetic Diagnosis and Individualized Intervention Through Next-generation Sequencing in Pre-symptomatic, Atypical, or Mildly Symptomatic Cases
2025
·
Kaori Aibara
, Yuri Kitamura
, et al.
·
Institutional Repositories DataBase (IRDB)
PDF
Effective Valproic Acid Treatment in Motor Function Is Caused by Possible Mechanism of Elevated Survival Motor Neuron Protein Related With Splicing Factor Gene Expression in Spinal Muscular Atrophy
2022
·
Kozue Takano
, Toshitaka Uchiyama
, et al.
·
Institutional Repositories DataBase (IRDB)
Imaging flow cytometry for identifying differences in SMN protein expression between spinal muscular atrophy patients and normal subjects
2017
·
Reiko Arakawa Masayuki Arakawa
, Kayoko Saito
·
Journal of Spine
3)Genetic testing for neuromusculardisorders
2017
·
Reiko Arakawa
·
Japanese Society of Child Neurology
Method of Evaluating Survival Motor Neuron Protein As An Outcome Measure of SMA-modifying Therapy
2017
·
Reiko Arakawa
, Arakawa Masayuki
, et al.
·
Brain and Development
脊髄性筋萎縮症におけるsmn1遺伝子の遺伝学的検査と遺伝カウンセリング | 文献情報 | J-global 科学技術総合リンクセンター
2017
·
荒川玲子
, 久保祐二
, et al.
·
日本遺伝カウンセリング学会誌
小児期脊髄性筋萎縮症に対する運動機能評価尺度について ~hfmse,chop Intendの検討~
2016
·
鈴木 隼人
, 長谷川 三希子
, et al.
·
理学療法学Supplement
Show more works
View as search
Works count:
27
Citation count:
401
H-index:
8
I10-index:
5
Year
Topic
Type